Description
MODIFICATION TO DECREASE EXCESS FUNDS.
Base award description: RADIOPHARMACEUTICALS FOR PORTLAND VAMC
Modification chain · 7 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2018-06-29+$50,000= $50,000
- Mod P000032018-07-01-$2,105= $47,895
- Mod P000042018-07-01+$10,270= $58,165
- Mod P000012018-11-21+$70,000= $128,165
- Mod P000022019-09-05+$28,000= $156,165
- Mod P000052021-07-16-$10,270= $145,895
- Mod P000062021-12-16-$2,266= $143,628
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2018-06-29 | +$50,000 | $50,000 | RADIOPHARMACEUTICALS FOR PORTLAND VAMC |
| Mod P00003· OTHER ADMINISTRATIVE ACTION | 2018-07-01 | −$2,105 | $47,895 | RADIOPHARMACEUTICALS FOR PORTLAND VAMC: ADD FY19 FUNDING TO CURRENT ORDER. |
| Mod P00004· OTHER ADMINISTRATIVE ACTION | 2018-07-01 | +$10,270 | $58,165 | RADIOPHARMACEUTICALS FOR PORTLAND VAMC: ADD FY19 FUNDING TO CURRENT ORDER. |
| Mod P00001· FUNDING ONLY ACTION | 2018-11-21 | +$70,000 | $128,165 | RADIOPHARMACEUTICALS FOR PORTLAND VAMC: ADD FY19 FUNDING TO CURRENT ORDER. |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-09-05 | +$28,000 | $156,165 | RADIOPHARMACEUTICALS FOR PORTLAND VAMC: ADD FY19 FUNDING TO CURRENT ORDER. |
| Mod P00005· FUNDING ONLY ACTION | 2021-07-16 | −$10,270 | $145,895 | MODIFICATION TO DECREASE EXCESS FUNDS. |
| Mod P00006· FUNDING ONLY ACTION | 2021-12-16 | −$2,266 | $143,628 | MODIFICATION TO DECREASE EXCESS FUNDS. |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI EQ4VSLH8RC33)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24826N0411 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $231,773 | FY2026 |
| 36C24126N0274 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $771,411 | FY2026 |
| 36C25226N0210 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $164,999 | FY2026 |
| 36C26126N0065 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $153,991 | FY2026 |
| 36C24825N0208 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $224,563 | FY2025 |
| 36C24125N0495 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $656,883 | FY2025 |
Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26026F0379 | COSETTE PHARMACEUTICALS, INC. | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $3,466 | FY2026 |
| 36C26026P0671 | MCKESSON PLASMA AND BIOLOGICS LLC | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $18,262 | FY2026 |
| 36C26026F0349 | AGIOS PHARMACEUTICALS, INC. | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $73,080 | FY2026 |
| 36C26026F0306 | BRACCO DIAGNOSTICS INC. | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $337,422 | FY2026 |
| 36C26026F0298 | PROGENICS PHARMACEUTICALS INC | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $469,134 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26018N1037_3600_VA26017D0044_3600 · retrieved 2026-09-26.